Mucormycosis: An Increasing Concern; Experience From A Tertiary Care Centre.
DOI:
https://doi.org/10.37506/0q362t59Keywords:
mucormycosis, Uncontrolled diabetes mellitus, Rhinocerebral.Abstract
Background: Mucormycosis is an angioinvasive life threatening infection caused by the fungus belonging to the order Mucorales and family Mucoraceae. The prevalence of mucormycosis is on a rising trend. The known risk factors for mucormycosis includes uncontrolled diabetes mellitus, malignancies such as lymphomas, leukemia, organ transplant, long term corticosteroid or immunosuppressive therapy, renal failure, burns, protein-energy-malnutrition etc.
Methods: This is a prospective study conducted over a period of six months. Samples showing broad aseptate ribbon like fungal hyphae were included in the study. Clinical, demographic details, risk factors, results of radiological and pathological investigations were collected and analysed.
Results: In the study period, 76 samples were received for KOH examination in the laboratory, out of which 15 samples were found to be positive for broad aseptate ribbon like fungal hyphae. The mean age of the study group was 43.4 years. Out of 15 patients, 66.6% were males and 33.3% were females. All the cases were of Rhinocerebral mucormycosis and uncontrolled diabetes mellitus was the risk factor present in all the cases. Five patients were diagnosed with diabetes at the time of admission. Three cases presented with diabetic ketoacidosis, two cases had chronic kidney disease and one was a known case of pulmonary tuberculosis.
Conclusion: In the past few years, there has been a steady increase in the cases of mucormycosis, both worldwide and in India. As the disease progresses rapidly, prompt diagnosis and early management plays a crucial role in survival of the patient.
References
Yadav S, Sharma A, Kothari N, Bhatia PK, Goyal S, Goyal A. Mucormycosis: A Case Series of Patients Admitted in Non-COVID-19 Intensive Care Unit of a Tertiary Care Center during the Second Wave. Indian J Crit Care Med. 2021 Oct;25(10):1193-1196.
Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and Diagnosis of Mucormycosis: An Update. J Fungi (Basel). 2020 Nov 2;6(4):265.
Slavin M etal. Invasive infections due to filamentous fungi other than Aspergillus: epidemiology and determinants of mortality. Clin Microbiol Infect. 2015 May;21(5):490.e1-10.
Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005 Jul;18(3):556-69.
Yong JY, Chong KL, Gan WF, Zaidan NZ. Mucormycosis: A Case Series. Cureus. 2023 Jul 4;15(7):e41375.
Sarvestani SA, Pishdad G, Bolandparvaz S. Predisposing Factors for Mucormycosis in Patients with Diabetes Mellitus; An Experience of 21 Years in Southern Iran. Bull Emerg Trauma. 2013 Oct;1(4):164-70.
Afroze SN, Korlepara R, Rao GV, Madala J. Mucormycosis in a diabetic patient: A case report with an insight into its pathophysiology. Contemp Clin Dent 2017;8:662-6.
Mohammadi R, Meidani M, Mostafavizadeh K, et al. Case series of rhinocerebral mucormycosis occurring in diabetic patients. Caspian J Intern Med 2015; 6(4):243-246.
Chakrabarti A, etal. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006 Jun;44(4):335-42.
Sharma A, Goel A. Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic. Folia Microbiol (Praha). 2022 Jun;67(3):363-387
Priya P, Ganesan V, Rajendran T, Geni VG. Mucormycosis in a Tertiary Care Center in South India: A 4-Year Experience. Indian J Crit Care Med. 2020 Mar;24(3):168-171.
Khanna M, Challa S, Kabeil AS, Inyang B, Gondal FJ, Abah GA, Minnal Dhandapani M, Manne M, Mohammed L. Risk of Mucormycosis in Diabetes Mellitus: A Systematic Review. Cureus. 2021 Oct 16;13(10):e18827.
Roushdy T, Hamid E. A case series of post COVID-19 mucormycosis-a neurological prospective. Egypt J Neurol Psychiatr Neurosurg. 2021;57(1):100.
Hoenigl M, etal. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022 Jul;3(7):e543-e552.
Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab. 2012 Mar;16 Suppl 1(Suppl1):S27-36
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047-53.
Anusuya, G.S, Ravi, R., Gopalakrishnan, S., Abiselvi, A., & Stephen, T. Prevalence of undiagnosed and uncontrolled diabetes mellitus among adults in South Chennai. International Journal Of Community Medicine And Public Health, 2018;5(12):5200–5204.
Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol 2021;69:2932-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Charu Nayyar, Dimple Kapoor, Mahesh Mohta, Sankalp Sethi, Navdeep Singh, P C Swami, Cherry Bansal

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
https://creativecommons.org/licenses/by-nc/2.0/deed.en